Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.54 USD | +0.08% | +0.42% | -2.66% |
Financials (USD)
Sales 2024 * | 2.34B | Sales 2025 * | 2.5B | Capitalization | 3.02B |
---|---|---|---|---|---|
Net income 2024 * | 144M | Net income 2025 * | 155M | EV / Sales 2024 * | 1.42 x |
Net Debt 2024 * | 305M | Net Debt 2025 * | 311M | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
19.8
x | Employees | 19,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.73% |
Latest transcript on Amedisys, Inc.
1 day | +0.18% | ||
1 week | +0.31% | ||
Current month | -0.60% | ||
1 month | -0.73% | ||
3 months | -2.95% | ||
6 months | -0.85% | ||
Current year | -2.74% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 23-04-09 | |
Scott Ginn
DFI | Director of Finance/CFO | 55 | 17-01-31 |
Paul Kusserow
CHM | Chairman | 62 | 14-12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 15-04-21 | |
Molly Joel Coye
BRD | Director/Board Member | 76 | 19-10-31 |
Vickie Capps
BRD | Director/Board Member | 62 | 19-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.18% | 8 M€ | +6.91% | ||
0.83% | 2 M€ | +12.97% | ||
0.24% | 464 M€ | -.--% | ||
0.17% | 46 M€ | +4.03% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 92.53 | +0.08% | 1 862 |
24-03-27 | 92.46 | +0.18% | 200,562 |
24-03-26 | 92.29 | +0.14% | 367,190 |
24-03-25 | 92.16 | +0.01% | 360,040 |
24-03-22 | 92.15 | 0.00% | 300,167 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.74% | 3.02B | |
0.00% | 1.74B | |
+11.73% | 1.66B | |
+42.53% | 595M | |
+11.69% | 580M | |
-27.37% | 423M | |
-9.83% | 151M | |
+5.77% | 70.3M |